Rubra Medicaments has informed about the board meeting of the company to be held on August 10, 2017 to consider the Change in the Name of the Company, Preferential Allotment of Warrants, shifting of Registered Office of the company and consequential Alteration in the Memorandum of Association, approval of Notice of Postal Ballot, and Approval of Notice of Annual General Meeting of the Company.
The above information is a part of company’s filings submitted to BSE.